Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Price updated todayFinancials updated Oct 22, 2026
Explore stock sections · swipe left or right
SXT · Price history
Price at last available close
$132.20
+$3.48 (+2.70%) 1M
2026-10-29
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Sensient Technologies Corporation, operating alongside its various subsidiaries, specializes in the creation, production, and global distribution of colors, flavorings, and an array of other specialized ingredients. The company's extensive market presence spans across North America, Europe, the Asia Pacific region, and numerous other international territories. Its operations are strategically organized into three main divisions: the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.
How they make money
Sensient Technologies Corporation operates as a global manufacturer and marketer of colors, flavors, and specialty ingredients. The company generates revenue by developing and producing customized ingredient systems for food, beverage, pharmaceutical, nutraceutical, and personal care manufacturers, leveraging advanced technologies at global production facilities.
Products & services
The company produces specialty food and beverage systems, essential oils, pharmaceutical and nutraceutical coatings, personal care colors and ingredients, and specialty chemicals for industrial applications.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Overall investment score · Quality, value, risk and opportunity
29
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
52
Fair
Financial Strength
53
Business Quality / Moat
30
Management
71
Growth Quality
45
Risk / Durability
82
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
23
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
30/100
Building Historical Record
Model Score 30/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
No strong positive signal is being highlighted from the currently available summary data.
What to watch
•Reverse-split headline · Oct 22, 2026
•Reverse-split headline · Aug 5, 2026
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
•Asset quality is a weaker factor
Company-specific research
Questions worth answering for SXT
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can SXT maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is SXT's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Is SXT's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•What future growth or profitability would be needed to justify SXT's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for SXT
Detected from reported data — verify before acting.
Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Reverse-split headline · Oct 22, 2026
China SXT Pharmaceuticals, Inc. Announces Share Consolidation — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
China SXT Pharmaceuticals, Inc. Announces Share Consolidation — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Advanced technology and R&D capabilities for customized ingredient systems.
+Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Chemicals - Specialty industry.
−Exposure to cybersecurity incidents.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak29/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Fair
53
Debt Cost3.8%
Debt Reduction YoY-22.9%
Debt / Equity0.65x
Tap for breakdown →
Revenue
Poor
19
Revenue YoY5.7%
Revenue CAGR5.2%
Net Margin9.3%
Tap for breakdown →
Asset
Poor
38
Asset Growth YoY10.9%
Liquidation/Share$29.58
Net Assets/MCap0.29x
Tap for breakdown →
Capital
Poor
12
Earnings Yield2.8%
Buyback Yield0.0%
Debt Cost3.8%
Tap for breakdown →
Management
Strong
71
ROIC7.9%
ROE12.5%
ROA6.7%
Tap for breakdown →
Moat
Poor
30
EPS Growth2.2%
FCF/Share Growth-21.4%
Rev/Share Growth3.0%
Tap for breakdown →
Valuation
Poor
10
Intrinsic Value$60.85
Value Reference$36.51
MOS-118.0%
Tap for breakdown →
Buffett
Poor
39
Revenue19
Moat30
Valuation10
Tap for breakdown →
MOS
Poor
0
MOS %-118.0%
Value Reference$36.51
Deep Discount Reference$24.34
Tap for breakdown →
Financial
Poor
29
Interest Coverage7.0x
ROIC7.9%
FCF Yield0.7%
Tap for breakdown →
Master
Poor
25
Financial29
Valuation10
Debt53
Tap for breakdown →
Resilience
Fair
52
Survival Years0.2 yrs
Current Ratio4.10x
FCF Margin2.4%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
3 historical score records available
Previous Score
29
Oct 1, 2026
Change
-0.1
points
Current Score
29
Oct 22, 2026
Category Changes
Revenue-0.1
Debt0
Assets-0.2
Capital0
Management0
Moat0
Valuation0
Buffett0
SXT decreased 0.1 points because some fundamentals weakened.
Projected Score
Projected Score
30
Projected Change
+1.2 points
Preliminary comparable-period financial changes suggest improvement of approximately 1.2 points. This is a projected estimate, not the official WallStreetScore.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
$1.70B
$1.61B
$1.56B
$1.46B
····
····
····
····
····
····
····
Cost of Revenue
$1.11B
$1.07B
$1.05B
$996.2M
····
····
····
····
····
····
····
Gross Profit
$590.2M
$539.3M
$507.1M
$460.3M
····
····
····
····
····
····
····
Research & Development
$0.00
$0.00
$49.1M
$48.1M
····
····
····
····
····
····
····
SG&A Expenses
$350.9M
$332.2M
$266.4M
$257.2M
····
····
····
····
····
····
····
Operating Expenses
$350.9M
$332.2M
$315.5M
$305.3M
····
····
····
····
····
····
····
EBITDA
$301.5M
$268.2M
$251.9M
$212.8M
····
····
····
····
····
····
····
Operating Income
$239.3M
$207.1M
$191.6M
$155.0M
····
····
····
····
····
····
····
Interest Expense
$30.9M
$29.6M
$28.8M
$25.2M
····
····
····
····
····
····
····
Income Before Tax
$208.4M
$177.5M
$162.8M
$129.9M
····
····
····
····
····
····
····
Income Tax Expense
$50.4M
$43.1M
$38.1M
$36.5M
····
····
····
····
····
····
····
Net Income
$158.0M
$134.5M
$124.7M
$93.4M
····
····
····
····
····
····
····
Basic EPS
$3.73
$3.18
$2.96
$2.22
····
····
····
····
····
····
····
Basic Shares
42.32M
42.24M
42.15M
42.03M
····
····
····
····
····
····
····
Diluted Shares
42.71M
42.59M
42.40M
42.24M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Margins expanded
What Weakened
Cash position declined
Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, net income margin. Pressure indicators included cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 11.6%. EPS increased 36.4%. Cash declined 45.3%. Total debt increased 3.7%. Net income margin improved by 2.0 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Log in to view dividend history.
Log In
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.